Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Fidia Spa ( (IT:FDA) ) is now available.
Fidia has reported the conversion of one bond from the fourth tranche of its 2026 convertible bond with warrants reserved to Global Growth Holding Limited, at a price of €0.01 per share. The conversion resulted in the issuance of 1,000,000 new shares, which are immediately admitted to trading, and reflects ongoing utilization of the company’s structured financing arrangement.
Following this transaction, the capital increase linked to the convertible program has reached €960,000 out of a total subscribed nominal amount of €1,000,000, with four bonds still outstanding and not yet converted. The company’s share capital rises by €10,000 to €10,807,761.90, bringing the total number of shares to 55,542,927, slightly diluting existing shareholders while strengthening Fidia’s equity base to support its industrial and market strategies.
The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.
More about Fidia Spa
Fidia S.p.A., based in Turin and listed on Euronext Milan, is a global player in the design, production and sale of high-performance integrated milling systems. Its technology is mainly used in the automotive mold and aerospace sectors, offering numerical controls, high-speed milling systems and CAM software that cover the entire milling process from programming to finished product.
Average Trading Volume: 1,510,996
Technical Sentiment Signal: Strong Sell
Current Market Cap: €511.9K
For a thorough assessment of FDA stock, go to TipRanks’ Stock Analysis page.